Skip to main content
Clinical Trials/ACTRN12623001018606
ACTRN12623001018606
Not Yet Recruiting
N/A

The effects of a combined exercise intervention on gut microbiomes and systemic inflammatory biomarkers in NAFLD patients

Mr Christiaan Hattingh0 sites46 target enrollmentSeptember 20, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Mr Christiaan Hattingh
Enrollment
46
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 20, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Mr Christiaan Hattingh

Eligibility Criteria

Inclusion Criteria

  • (i)A diagnosis of NAFLD
  • (ii)No other liver disease or cancer present
  • (iii)Other well\-managed comorbidities, e.g. Type 2 Diabetes Mellitus (T2DM), and hypertension, are approved for the study
  • (iv)No recent or current exercise performed
  • (v)Commit to the cross\-sectional study and assess for the longitudinal study
  • (vi)Complete consent form

Exclusion Criteria

  • (i) Younger than 18 years of age
  • (ii) Serious cardiovascular, respiratory, or neurological diseases and cancers
  • (iii) Poorly controlled hypertension, glucose regulation or other serious chronic diseases
  • (iv) A disability that could prevent the completion of exercises
  • (v) High\-risk participants with contraindications to exercise
  • (vi) Currently exercising more than 60 minutes per week
  • (vii) Participation in conflicting studies
  • (viii) Participants with internal artefacts that may obscure DXA readings
  • (ix) Participants who are pregnant, attempting to conceive or lactating.
  • (x) Participants exposed to radiation levels deemed unsafe in the DXA pre\-testing preparation checklist.

Outcomes

Primary Outcomes

Not specified

Similar Trials